In this episode, Maya meets Moe Alsumidaie, who is the Chief Editor of The Clinical Trial Vanguard. Moe holds two decades of experience in the clinical trials industry.  The Clinical Trial Vanguard is an online platform that provides comprehensive information, analysis, and news related to clinical trials. It caters to a wide audience, including researchers, healthcare professionals, investors, and industry enthusiasts, aiming to keep them informed about the latest developments in clinical trials.  Maya and Moe delve into the world of clinical trials, discussing decentralized clinical trials, the role of AI, regulatory trends, and patient-centric design. Moe shares insights on how to enhance the success and efficiency of clinical trials, emphasizing innovations like digital twins, digital biomarkers, and the need for trust and collaboration in the field. (02:42) Meet Moe Alsumidaie (04:29) Is the Momentum for DCT's Dying (09:02) Current Trends and Future Outlook of Decentralized Clinical Trials  (14:00) The Role of AI in Clinical Trials (22:13) How Digital BiomarkersTransform Clinical Trials (25:35) Examples of Patient-Centric Approaches in Clinical Trials Follow our LinkedIn page for more insights from the world of clinical trials. Maya Zlatanova, CEO of TrialHub Moe Alsumidaie, Chief Editor of The Clinical Trial Vanguard Must-reads from The Clinical Trial Vanguard Your Guide to Validate Clinical Trial DHTs The Future of DCTs Stanford’s New Leap in Personalized Medicine and Trials Digital Twins: The Future of Clinical Trials